Systematic analysis of miRNAs in patients with postmenopausal osteoporosis

References

• Alejandro P, Constantinescu F. A review of osteoporosis in the older adult: an update. Rheum Dis Clin North Am. 2018;44(3):437–451.
   PubMed Web of Science ®Google Scholar
• Wade SW, Strader C, Fitzpatrick LA, et al. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos. 2014;9:182.
   PubMed Web of Science ®Google Scholar
• Seibel MJ, Dunstan CR, Zhou H, et al. Sex steroids, not FSH, influence bone mass. Cell. 2006;127(6):1079.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang Y, Zhang CL, et al. Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network. Exp Ther Med. 2019;17(4):3155–3161.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44.
   PubMed Web of Science ®Google Scholar
• Shi Z, Zhou H, Lu L, et al. The roles of microRNAs in spinal cord injury. Int J Neurosci. 2017;127(12):1104–1115.
   PubMed Web of Science ®Google Scholar
• Javid H, Soltani A, Mohammadi F, et al. Emerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesis. J Cell Biochem. 2019;120(7):10874–10883.
   Web of Science ®Google Scholar
• Hackl M, Heilmeier U, Weilner S, et al. Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases? Mol Cell Endocrinol. 2016;432:83–95.
   PubMed Web of Science ®Google Scholar
• Lin C, Yu S, Jin R, et al. Circulating miR-338 cluster activities on osteoblast differentiation: potential diagnostic and therapeutic targets for postmenopausal osteoporosis. Theranostics. 2019;9(13):3780–3797.
   PubMed Web of Science ®Google Scholar
• Meng J, Zhang D, Pan N, et al. Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis. PeerJ. 2015;3:e971.
   PubMed Web of Science ®Google Scholar
• Qiu J, Huang G, Na N, et al. MicroRNA-214-5p/TGF-β/Smad2 signaling alters adipogenic differentiation of bone marrow stem cells in postmenopausal osteoporosis. Mol Med Rep. 2018;17(5):6301–6310.
   PubMed Web of Science ®Google Scholar
• Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146–D152.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25–29.
   PubMed Web of Science ®Google Scholar
• Wixon J, Kell D. The Kyoto Encyclopedia of Genes and Genomes–KEGG. Yeast. 2000;17:48–55.
   PubMed Web of Science ®Google Scholar
• Jia J, Zhou H, Zeng X, et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. Mol Med Rep. 2017;15(4):1539–1546.
   PubMed Web of Science ®Google Scholar
• Cao Z, Moore BT, Wang Y, et al. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PLoS One. 2014;9(5):e97098.
   PubMed Web of Science ®Google Scholar
• Wang W, Yang L, Zhang D, et al. MicroRNA-218 negatively regulates osteoclastogenic differentiation by repressing the nuclear factor-κB signaling pathway and targeting tumor necrosis factor receptor 1. Cell Physiol Biochem. 2018;48(1):339–347.
   PubMedGoogle Scholar
• Song T, Lin T, Ma J, et al. Regulation of TRPV5 transcription and expression by E2/ERα signalling contributes to inhibition of osteoclastogenesis . J Cell Mol Med. 2018;22(10):4738–4750.
   PubMed Web of Science ®Google Scholar
• Li J, Hao L, Wu J, et al. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling. Int J Mol Med. 2016;37(4):901–910.
   PubMed Web of Science ®Google Scholar
• Lo KW, Kan HM, Ashe KM, et al. The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tissue Eng Regen Med. 2012;6(1):40–48.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Kitaura Y, Gu H, et al. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc Natl Acad Sci USA. 2006;103(2):395–400.
   PubMed Web of Science ®Google Scholar
• Hughes DE, Dai A, Tiffee JC, et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med. 1996;2(10):1132–1136.
   PubMed Web of Science ®Google Scholar
• Lin XS, Wang HY, Zhang Z, et al. Effects of acupoint application therapy with TianGui powder on osteoporosis in ovariectomized rats through TGF-beta1 and Smad2/3 signaling pathway. Orthop Surg. 2019;11(1):143–150.
   PubMed Web of Science ®Google Scholar
• Ou L, Wei P, Li M, et al. Inhibitory effect of Astragalus polysaccharide on osteoporosis in ovariectomized rats by regulating FoxO3a/Wnt signaling pathway. Acta Cir Bras. 2019;34:e201900502.
   PubMed Web of Science ®Google Scholar
• Binder NB, Niederreiter B, Hoffmann O, et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med. 2009;15(4):417–424.
   PubMed Web of Science ®Google Scholar